000 | 01150 a2200277 4500 | ||
---|---|---|---|
005 | 20250517054505.0 | ||
264 | 0 | _c20180213 | |
008 | 201802s 0 0 eng d | ||
022 | _a1477-092X | ||
024 | 7 |
_a10.1177/1078155215608522 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLoboda, C | |
245 | 0 | 0 |
_aIncompatibility of busulfan with 1 ml Luer-Lock syringes. _h[electronic resource] |
260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cJun 2016 |
||
300 |
_a571-2 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
650 | 0 | 4 |
_aBusulfan _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPolymers _xadverse effects |
650 | 0 | 4 |
_aSyringes _xadverse effects |
700 | 1 | _aLider, P | |
700 | 1 | _aVigneron, J | |
773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 22 _gno. 3 _gp. 571-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155215608522 _zAvailable from publisher's website |
999 |
_c25313450 _d25313450 |